- Home
- MCRB vs LOAN Comparison
MCRB vs LOAN Comparison
Compare MCRB & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | LOAN |
|---|---|---|
| Founded | 2010 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2M | 38.8M |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MCRB | LOAN |
|---|---|---|
| Price | $1.88 | $3.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 70.9K | 42.4K |
| Earning Date | 11-13-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 12.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | $789,000.00 | ★ $8,666,307.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.68 | $3.31 |
| 52 Week High | $29.98 | $5.01 |
Technical Indicators
Market Signals| Indicator | MCRB | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 25.98 | 36.36 |
| Support Level | N/A | $3.31 |
| Resistance Level | $9.53 | $4.50 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 18.78 | 31.82 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.